Track topics on Twitter Track topics that are important to you
A round of Series A1 financing has brought in $4 million for molecular diagnostic startup Prominex. -More-
Start-up molecular diagnostics firm Prominex Inc. raised $4mm in a Series A-1 financing from Casdin Capital and company CEO and founder Paul Thomas.
Funding development of 5-minute point-of-care molecular diagnostics Prominex, Inc., a molecular diagnostic company focused on point-of-care infectious disease testing, today a...
Prominex was founded in 2016 with a primary focus on the development of molecular diagnostic assays for point-of-care infectious disease testing. The novel molecular amplification...
We have published hundreds of Prominex, Inc. news stories on BioPortfolio along with dozens of Prominex, Inc. Clinical Trials and PubMed Articles about Prominex, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prominex, Inc. Companies in our database. You can also find out about relevant Prominex, Inc. Drugs and Medications on this site too.
Immunoassay - ELISA
Immunoassays are quick and accurate tests to detect specific molecules. Immunoassays rely on an antibody to bind to the specific structure of a molecule. Antibodies are proteins generated by animals in response to the invasion of a foreign molecule (anti...
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...